We are live on
!
Find out more
MWNA
Marshall Wace North America Portfolio holdings
AUM
$23.5B
1-Year Est. Return
46.46%
This Fund
S&P 500
This Quarter
Est. Return
+29%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$15.1B
AUM Growth
+$1.94B
(+15%)
Cap. Flow
-$956M
Cap. Flow
% of AUM
-6.31%
Top 10 Holdings %
Top 10 Hldgs %
19.25%
Holding
1,647
New
467
Increased
323
Reduced
312
Closed
527
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$148M |
| 2 |
Humana
HUM
|
+$109M |
| 3 |
Meta Platforms (Facebook)
META
|
+$102M |
| 4 |
Motorola Solutions
MSI
|
+$89.2M |
| 5 |
Lowe's Companies
LOW
|
+$82M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$208M |
| 2 |
Johnson & Johnson
JNJ
|
+$190M |
| 3 |
Pfizer
PFE
|
+$166M |
| 4 |
NVIDIA
NVDA
|
+$154M |
| 5 |
Adobe
ADBE
|
+$134M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.79% |
| 2 | Technology | 18.34% |
| 3 | Consumer Discretionary | 12.92% |
| 4 | Financials | 8.19% |
| 5 | Industrials | 8.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
WaFd
WAFD
$2.76B
| $1.02M | 0.01% |
38,133
-37,865
| -50% | -$975K |
|
752
Xcel Energy
XEL
$48B
| $1.02M | 0.01% |
+16,299
| New | +$1.03M |
|
|
ESPR
753
DELISTED
Esperion Therapeutics
ESPR
| $1.01M | 0.01% |
+19,763
| New | +$827K |
|
754
Twilio
TWLO
$38B
| $1.01M | 0.01% |
+4,619
| New | +$742K |
|
|
AVLR
755
DELISTED
Avalara, Inc.
AVLR
| $1.01M | 0.01% |
7,571
-3,081
| -29% | -$303K |
|
756
ICU Medical
ICUI
$4.56B
| $999K | 0.01% |
5,427
+5,327
| +5,327% | +$1.06M |
|
757
Mattel
MAT
$4.21B
| $996K | 0.01% |
102,989
+73,052
| +244% | +$663K |
|
758
IDEX
IEX
$17.2B
| $994K | 0.01% |
6,289
-150,995
| -96% | -$23.1M |
|
|
RNAM
759
DELISTED
Avidity Biosciences
RNAM
| $994K | 0.01% |
+35,182
| New | +$1.01M |
|
|
UCTT
760
Ultra Clean Holdings
UCTT
$3.72B
| $993K | 0.01% |
+43,902
| New | +$835K |
|
761
Synchrony
SYF
$25.4B
| $990K | 0.01% |
+44,691
| New | +$871K |
|
762
SPX Corp
SPXC
$10.6B
| $987K | 0.01% |
+24,008
| New | +$904K |
|
|
MOR
763
DELISTED
MorphoSys AG American Depositary Shares
MOR
| $986K | 0.01% |
+31,097
| New | +$906K |
|
764
Federal Signal
FSS
$7.74B
| $978K | 0.01% |
+32,876
| New | +$930K |
|
|
MMX
765
DELISTED
Maverix Metals Inc. Common Shares
MMX
| $964K | 0.01% |
+217,000
| New | +$933K |
|
|
GBIO
766
DELISTED
Generation Bio
GBIO
| $961K | 0.01% |
+4,578
| New | +$1.02M |
|
767
Oil States International
OIS
$534M
| $956K | 0.01% |
201,101
-181,357
| -47% | -$697K |
|
768
Cogent Communications
CCOI
$528M
| $953K | 0.01% |
+12,326
| New | +$998K |
|
|
SFIX
769
Stitch Fix
SFIX
$530M
| $952K | 0.01% |
+38,187
| New | +$754K |
|
770
Helios Technologies
HLIO
$2.69B
| $951K | 0.01% |
+25,555
| New | +$871K |
|
771
Ziff Davis
ZD
$2B
| $947K | 0.01% |
+17,248
| New | +$1.13M |
|
772
Cohen & Steers
CNS
$4.22B
| $940K | 0.01% |
+13,810
| New | +$833K |
|
773
Telkom Indonesia
TLK
$14.7B
| $933K | 0.01% |
42,660
-50,038
| -54% | -$1.06M |
|
774
Zumiez
ZUMZ
$330M
| $929K | 0.01% |
+33,923
| New | +$770K |
|
775
Caesars Entertainment
CZR
$6.13B
| $928K | 0.01% |
23,173
-11,598
| -33% | -$321K |
|
Similar funds
TGHSA
PAM
HB
MWA
3SCA
HFCIV
DVC
NAM
Marshall Wace North America's Q2 2020 Portfolio in Review
As of Q2 2020, Marshall Wace North America held 1,647 positions worth $15.1B, up 15% from $13.2B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Marshall Wace North America withdrew a net $956M in Q2 2020, closing 527 positions and reducing 312 holdings. Its most notable exit was Becton Dickinson, an estimated $86.4M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 28% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Marshall Wace North America opened a new position in Motorola Solutions worth $88.4M.
- Marshall Wace North America's largest Q2 2020 buy was Motorola Solutions: 630,587 shares worth $88.4M.
- Marshall Wace North America added most to JPMorgan Chase in Q2 2020, an estimated $148M increase.
- Marshall Wace North America's biggest Q2 2020 reduction was Merck, cutting an estimated $208M.
- Marshall Wace North America fully exited Becton Dickinson in Q2 2020, selling an estimated $86.4M.
- Marshall Wace North America's ten largest holdings make up 19% of its $15.1B portfolio in Q2 2020.
- Marshall Wace North America opened 467 new positions and closed 527 in Q2 2020.
- Marshall Wace North America's portfolio value rose 15% quarter-over-quarter to $15.1B.
Based on Marshall Wace North America's 13F filing for Q2 2020, filed 13 Aug 2020.